Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News BioVie Inc. BIVI

BioVie Inc is a company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is currently focused on developing and commercializing BIV201, a novel investigational approach to the treatment of ascites due to chronic liver cirrhosis. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver...

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:BIVI)

Fundamentals Snapshot (NDAQ:BIVI)

Opinion & Analysis (NDAQ:BIVI)

No current opinion is available.

Bullboard Posts (NDAQ:BIVI)

Up 48 %

but nobody on SH cares . 
divime1 - July 27, 2018

BioVie Receives FDA Clearance

http://www.marketwired.com/press-release/biovie-receives-fda-clearance-ind-application-phase-2a-clinical-trial-refractory-ascites-otcqb...
divime1 - April 3, 2017